Clinical Trials Browser

Neoplasms, Lymphoma, Large B-Cell, Diffuse

Breast Neoplasms

Nasopharyngeal Carcinoma

Triple Negative Breast Neoplasms

Esophageal Neoplasms

Esophageal Squamous Cell Carcinoma

Colonic Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Advanced Tumor of Digestive Tract or Urinary System

Rectal Neoplasms

Esophageal Neoplasms

Pathologic Complete Response, Breast Neoplasms

Lymphocele, Varicose Veins

Hormone Receptor Positive Advanced Breast Cancer

Hormone Receptor Positive Advanced Breast Cancer

Carcinoma, Transitional Cell

HER2-positive

Platinum-resistant Recurrent Ovarian Cancer

Breast Neoplasms

Breast Neoplasms

Esophageal Squamous Cell Carcinoma

Stomach Neoplasms

Colorectal Neoplasms

Advanced Colorectal Cancer

Carcinoma, Non-Small-Cell Lung

Lymphoma, Extranodal NK-T-Cell

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Stomach Neoplasms

Leiomyosarcoma

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

Breast Neoplasms, Cardiovascular Diseases

Esophageal Neoplasms

Breast Neoplasms

Triple Negative Breast Neoplasms

HER2-positive Breast Cancer

Lymphoma, Extranodal NK-T-Cell

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

Breast Neoplasms

Colonic Neoplasms

Small Cell Lung Carcinoma

Breast Neoplasms

Mesothelioma, Malignant

Rectal Neoplasms

Advanced Breast Cancer

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Lymphoma, Recurrence

Clinical Trials

MOSAIC

HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer

Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy

AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage

Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer

MATCH

A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic Resection

A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors

Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer

Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 Resection

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

Management of a Giant Lymphocele Following Varicose Vein Surgery - A Case Report

CAPACITY

Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

APPROVE

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study

APEX

Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL

Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in China

A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast Cancer

Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China

Radiotherapy for Extracranial Oligometastatic Breast Cancer

Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer

Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer

Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL

LM-HNSCC

Characteristics and Treatment Trends of Young Breast Cancer in China

The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer

Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction

Real World Study of MPM in China

Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib

Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1

Ara-C

Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies